Media Summary: Rob Fraser, MD and Michelle Kittleson, MD, PhD discuss the differences between We are joined by Dr Ahmad Masri (Oregon Health & Science University Medical Group, US) to discuss the findings from ... ... Cardiomyopathy Program, explains the difference between

Obstructive And Nonobstructive Hcm - Detailed Analysis & Overview

Rob Fraser, MD and Michelle Kittleson, MD, PhD discuss the differences between We are joined by Dr Ahmad Masri (Oregon Health & Science University Medical Group, US) to discuss the findings from ... ... Cardiomyopathy Program, explains the difference between Host Dr. Eli Friedman chats with Dr. Ahmad Masri, of Oregan Health Sciences University When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a ... In this episode of In the Thick of It, hosts Dr. Betty Raman and Dr. James MacNamara welcome Professor Martin Maron, Director of ...

Aficamten has outperformed placebo among patients with symptomatic

Photo Gallery

Obstructive and Nonobstructive HCM
Hypertrophic Cardiomyopathy (HCM) Mechanism of Disease Video
In The Thick of It Podcast Ep 10: Advances in Nonobstructive HCM with Dr. Lyle and Dr. Kittleson
Hypertrophic Cardiomyopathy Explained: Symptoms, Causes & Treatments
HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in Non-obstructive Hypertrophic Cardiomyopathy
Tell Me More: Hypertrophic Cardiomyopathy
HCM Patient Symposium 2025 | Non-obstructive-Apical Variant HCM - Jose Madrazo, MD
HCMS In the Thick of It Ep. 5 - What's Next for Non-obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM): Managing Symptoms
Obstructive Hypertrophic Cardiomyopathy (NORD)
Episode 27 - Metabolic Modulation in Non-Obstructive HCM: Exploring the FORTITUDE Trial
ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy
View Detailed Profile
Obstructive and Nonobstructive HCM

Obstructive and Nonobstructive HCM

Rob Fraser, MD and Michelle Kittleson, MD, PhD discuss the differences between

Hypertrophic Cardiomyopathy (HCM) Mechanism of Disease Video

Hypertrophic Cardiomyopathy (HCM) Mechanism of Disease Video

How is the heart with

In The Thick of It Podcast Ep 10: Advances in Nonobstructive HCM with Dr. Lyle and Dr. Kittleson

In The Thick of It Podcast Ep 10: Advances in Nonobstructive HCM with Dr. Lyle and Dr. Kittleson

Are the symptoms of

Hypertrophic Cardiomyopathy Explained: Symptoms, Causes & Treatments

Hypertrophic Cardiomyopathy Explained: Symptoms, Causes & Treatments

Hypertrophic Cardiomyopathy

HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in Non-obstructive Hypertrophic Cardiomyopathy

HFA 23: REDWOOD-HCM-Cohort 4: Aficamten in Non-obstructive Hypertrophic Cardiomyopathy

We are joined by Dr Ahmad Masri (Oregon Health & Science University Medical Group, US) to discuss the findings from ...

Tell Me More: Hypertrophic Cardiomyopathy

Tell Me More: Hypertrophic Cardiomyopathy

... Cardiomyopathy Program, explains the difference between

HCM Patient Symposium 2025 | Non-obstructive-Apical Variant HCM - Jose Madrazo, MD

HCM Patient Symposium 2025 | Non-obstructive-Apical Variant HCM - Jose Madrazo, MD

HCM

HCMS In the Thick of It Ep. 5 - What's Next for Non-obstructive Hypertrophic Cardiomyopathy

HCMS In the Thick of It Ep. 5 - What's Next for Non-obstructive Hypertrophic Cardiomyopathy

Host Dr. Eli Friedman chats with Dr. Ahmad Masri, of Oregan Health Sciences University

Hypertrophic Cardiomyopathy (HCM): Managing Symptoms

Hypertrophic Cardiomyopathy (HCM): Managing Symptoms

When patients present with symptoms such as fatigue, fainting, shortness of breath, chest pain or heart palpitations without a ...

Obstructive Hypertrophic Cardiomyopathy (NORD)

Obstructive Hypertrophic Cardiomyopathy (NORD)

What is

Episode 27 - Metabolic Modulation in Non-Obstructive HCM: Exploring the FORTITUDE Trial

Episode 27 - Metabolic Modulation in Non-Obstructive HCM: Exploring the FORTITUDE Trial

In this episode of In the Thick of It, hosts Dr. Betty Raman and Dr. James MacNamara welcome Professor Martin Maron, Director of ...

ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy

ACACIA-HCM: Aficamten Beats Placebo in Non-Obstructive Hypertrophic Cardiomyopathy

Aficamten has outperformed placebo among patients with symptomatic

Hypertrophic Cardiomyopathy: What is it and how is it treated?

Hypertrophic Cardiomyopathy: What is it and how is it treated?

Learn why people have